Laboratories Ltd
Last updated on 2017-08-28T12:08+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| Laboratories Ltd | EN | 99.31% |
| Laboratories Ltd | DE | 0.69% |
| Type | Entity Name | Count |
|---|---|---|
 | Dr Reddy | 8.31% |
 | Inc | 5.81% |
| Direct Investment Fund | 3.10% |
| Pfizer Inc | 2.60% |
| Reuters Group | 1.80% |
| Narendra Modi | 1.50% |
| British | 1.40% |
| Novartis | 1.30% |
| Serum Institute | 1.20% |
| Commission | 1.20% |
| Oxford University | 1.10% |
| World Health Organization | 1.10% |
| CIS | 1.10% |
| Copyright | 1.00% |
| Pvt Ltd | 0.90% |
| Five Forces | 0.90% |
| GlaxoSmithKline | 0.90% |
| Thermo Fisher Scientific | 0.90% |
| Regulation Services | 0.90% |
| Solutions | 0.80% |
| Thermo Fisher Scientific Inc | 0.80% |
| Abbott Laboratories | 0.80% |
| SA | 0.80% |
| Pharmaceuticals Inc | 0.80% |
| International Ltd | 0.70% |
| Roche Holding AG | 0.70% |
| Eli Lilly | 0.70% |
| Table | 0.70% |
| Ekke Primauno | 0.70% |
| Fujitsu | 0.70% |
| Type | Entity Name | Score |
|---|---|---|
| Dr Reddy | 0.0811 |
| Direct Investment Fund | 0.0299 |
| Leif Nilsson | 0.0238 |
| Novartis | 0.0127 |
| CIS | 0.0104 |
| Inc | 0.0091 |
| David Grondin | 0.009 |
| Thermo Fisher Scientific | 0.0089 |
| Five Forces | 0.0088 |
| Pvt Ltd | 0.0087 |
| Regulation Services | 0.0086 |
| GlaxoSmithKline | 0.0084 |
| Thermo Fisher Scientific Inc | 0.0079 |
| International Ltd | 0.0073 |
| Pharmaceuticals Inc | 0.0071 |
| Fujitsu | 0.0071 |
| Narendra Modi | 0.007 |
| Eli Lilly | 0.007 |
| Oxford University | 0.0069 |
| Roche Holding AG | 0.0069 |
| Abbott Laboratories | 0.0065 |
| Cadila Healthcare | 0.0061 |
| Boehringer Ingelheim | 0.0061 |
| Serum Institute | 0.006 |
| Teva Pharmaceuticals | 0.006 |
| Fujitsu Limited | 0.0059 |
| Fujitsu Ltd | 0.0059 |
| Solutions | 0.0058 |
| James Flynn | 0.0058 |
| Table | 0.0056 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Tuesday, March 2, 2021
1:43:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 